Kehr W - Search Results

1

[Neuropsychotropic activity of bicyclo[2.2.1]-heptane dopamine analogs].

Rehse K, Sparfeldt P, Kehr W. Rehse K, et al. Among authors: kehr w. Arch Pharm (Weinheim). 1987 Oct;320(10):1042-50. doi: 10.1002/ardp.198700007. Arch Pharm (Weinheim). 1987. PMID: 3435230 German. No abstract available.

2

[Neuropsychotropic activity of dopamine analogous phenylpropyl- and phenylcyclopropylpiperidines (author's transl)].

Rehse K, Behncke S, Siemann U, Kehr W. Rehse K, et al. Among authors: kehr w. Arch Pharm (Weinheim). 1980 Mar;313(3):221-9. doi: 10.1002/ardp.19803130306. Arch Pharm (Weinheim). 1980. PMID: 7369834 German. No abstract available.

3

[Neuropsychotropic activity of dopamine-analog 1,2,3,4-tetrahydro-beta-carbolines. 2. Alteration of activity by substituents].

Rehse K, Piesker G, Kehr W, Wachtel H. Rehse K, et al. Among authors: kehr w. Arch Pharm (Weinheim). 1979 Jul;312(7):597-603. doi: 10.1002/ardp.19793120707. Arch Pharm (Weinheim). 1979. PMID: 496580 German. No abstract available.

4

[Dopamine analogous piperidines and piperazines (author's transl)].

Rehse K, Fredrich D, Kehr W. Rehse K, et al. Among authors: kehr w. Arch Pharm (Weinheim). 1979 Aug;312(8):670-81. doi: 10.1002/ardp.19793120806. Arch Pharm (Weinheim). 1979. PMID: 496583 German. No abstract available.

5

[Neuropharmacological investigation of a new antidopaminergic tetrahydro-beta-carboline (DTHN) (author's transl)].

Kehr W, Horowski R, Schulte-Sienbeck H, Rehse K. Kehr W, et al. Arch Pharm (Weinheim). 1978 Oct;311(10):874-8. doi: 10.1002/ardp.19783111012. Arch Pharm (Weinheim). 1978. PMID: 736757 German. No abstract available.

6

[Receptor affinity of ecliptic fixed tryptamine and serotonin analogs].

Rehse K, Peetsch R, Kehr W. Rehse K, et al. Among authors: kehr w. Arch Pharm (Weinheim). 1987 Oct;320(10):1072-83. doi: 10.1002/ardp.198700011. Arch Pharm (Weinheim). 1987. PMID: 3435231 German. No abstract available.

7

[Neuropsychotropic activity of dopamine analogous 4,7-methanoisoindoles (author's transl)].

Rhese K, Mattern G, Kehr W, Paschelke G. Rhese K, et al. Among authors: kehr w. Arch Pharm (Weinheim). 1979 Dec;312(12):982-94. doi: 10.1002/ardp.19793121203. Arch Pharm (Weinheim). 1979. PMID: 543790 German. No abstract available.

8

The anxiolytic activity of beta-carboline derivatives in mice, and its separation from ataxic properties.

Stephens DN, Kehr W, Wachtel H, Schmiechen R. Stephens DN, et al. Among authors: kehr w. Pharmacopsychiatry. 1985 Jan;18(1):167-70. doi: 10.1055/s-2007-1017357. Pharmacopsychiatry. 1985. PMID: 2859620 No abstract available.

9

Central antidopaminergic properties of 2-bromolisuride, an analogue of the ergot dopamine agonist lisuride.

Wachtel H, Kehr W, Sauer G. Wachtel H, et al. Among authors: kehr w. Life Sci. 1983 Dec 26;33(26):2583-97. doi: 10.1016/0024-3205(83)90342-9. Life Sci. 1983. PMID: 6607392

10

ZK 91296, a partial agonist at benzodiazepine receptors.

Petersen EN, Jensen LH, Honoré T, Braestrup C, Kehr W, Stephens DN, Wachtel H, Seidelman D, Schmiechen R. Petersen EN, et al. Among authors: kehr w. Psychopharmacology (Berl). 1984;83(3):240-8. doi: 10.1007/BF00464788. Psychopharmacology (Berl). 1984. PMID: 6089246

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters